Hemant Surgical Industries Share Price Today | Stock Price & Hemant Surgical Industries Share Screener
Track the current Hemant Surgical Industries share price and stock price live with TickJournal's free stock screener. Track Hemant Surgical Industries market cap to gauge the company's total market size. Use the Hemant Surgical Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Hemant Surgical Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Hemant Surgical Industries Share Price Chart
Track the current stock price of Hemant Surgical Industries with an interactive chart. Analyse HSIL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Hemant Surgical Industries stock quote in one place.
Hemant Surgical Industries Company Profile - Fundamental Screener
Screen Hemant Surgical Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HSIL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Equipment & Supplies industry, and it trades under ISIN INE0GYI01028.
Company Details
Classification
Identifiers and Leadership
Hemant Surgical Industries Balance Sheet Screener
Screen HSIL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹274, up from ₹148 in 2025.
Latest statistics put total assets at ₹274 and shareholder funds at ₹138, with a leverage ratio of 0.40.
| Item | 2026 | 2025 |
|---|---|---|
Assets |
||
| Total Assets | 274 | 148 |
| Current Assets | 0 | 0 |
| Fixed Assets | 53 | 40 |
Liabilities |
||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 4 | 24 |
| Non-Current Liabilities | 0 | 0 |
Shareholders' Equity |
||
| Total Equity | 138 | 63 |
| Share Capital | 13 | 10 |
| Reserves & Surplus | 114 | 53 |
Hemant Surgical Industries Income Statement Screener - Profit & Revenue Analysis
Screen Hemant Surgical Industries income statement and profit fundamentals. Analyze HSIL quarterly results. Hemant Surgical Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹238 and net profit of ₹18.
| Item | None-None | 2026-March | 2025-March |
|---|---|---|---|
Revenue and Expenses | |||
| Revenue | 0 | 238 | 112 |
| Expenses | 0 | 209 | 98 |
Operating Costs and Margins | |||
| EBITDA | 0 | 29 | 14 |
| Operating Profit % | 0.00% | 10.00% | 9.00% |
| Depreciation | 0 | 2 | 1 |
| Interest | 0 | 4 | 2 |
Profit and Earnings | |||
| Profit Before Tax | 0 | 24 | 11 |
| Tax | 0 | 5 | 2 |
| Net Profit | 0 | 18 | 8 |
| EPS | 0.00 | 15.39 | 7.70 |
Hemant Surgical Industries Cash Flow Screener - Liquidity Fundamentals
Screen HSIL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹32, and net cash flow was an inflow of ₹34.
Over the same period, investing activities used ₹3 and financing activities provided ₹69.
| Item | 2026-March | 2025-March |
|---|---|---|
Cash from Operations and Investing | ||
| Operating Activities | -32 | 5 |
| Investing Activities | -3 | -30 |
Financing and Net Cash | ||
| Financing Activities | 69 | 22 |
| Net Cash Flow | 34 | -4 |
Hemant Surgical Industries Shareholding Pattern Screener
See Hemant Surgical Industries shareholding pattern with promoter, FII, and DII holdings. Check Hemant Surgical Industries promoter holding and ownership changes for HSIL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 52.83%, foreign institutions 0.14%, domestic institutions 9.62% and the public 22.61%, spread across 948 shareholders.
The shareholder count was 948 in 2026-Mar, compared with 948 in 2026-May.
| Item | 2026-Mar | 2026-May | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 52.83% | 52.83% | 52.83% | 73.56% | 58.90% | 58.90% | 73.56% | 73.56% |
Institutional Investors | ||||||||
| FII Holding | 0.14% | 0.14% | 0.00% | 0.39% | 0.15% | 0.15% | 0.00% | 0.00% |
| DII Holding | 9.62% | 19.94% | 19.94% | 1.11% | 10.81% | 10.81% | 1.97% | 1.13% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.61% | 22.61% | 23.24% | 20.87% | 23.17% | 23.22% | 20.64% | 20.24% |
| Other Holding | 14.80% | 4.49% | 3.99% | 4.06% | 6.97% | 6.91% | 3.82% | 5.07% |
| Shareholder Count | 948 | 948 | 1,202 | 1,229 | 748 | 758 | 1,229 | 1,248 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Hemant Surgical Industries. Hemant Surgical Industries dividend yield can be compared with peers and other stocks in the market.
Hemant Surgical Industries Stock Index Membership - Nifty & Sensex
See which indices include Hemant Surgical Industries stock. Check HSIL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Hemant Surgical Industries Market Events Screener - Corporate Actions
Get Hemant Surgical Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Hemant Surgical Industries stock events that may affect HSIL share price, along with derivatives, futures and options activity and sector gainers.
9 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.
It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated May 15, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-14 | 2026-11-14 | Quarterly Result Announcement | NA | 5.00% |
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 58.20% |
| 2026-05-15 | 2026-05-15 | Quarterly Result Announcement | NA | 29.62% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.00% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | 21.31% |
| 2025-08-30 | 2025-08-30 | Extraordinary General Meeting | NA | 24.79% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.94% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -0.31% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | -3.74% |
Hemant Surgical Industries Competitors Screener - Peer Stocks Comparison
Screen HSIL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Molbio Diagnostics | 17,103 | 120.80 | 1,455 | 41.57% | 164 | 60.50 |
| Poly Medicure | 16,721 | 53.80 | 1,995 | 13.43% | 321 | 57.87 |
| Sahajanand Medical Technologies | 5,579 | 79.90 | 1,219 | 17.64% | 69 | 76.00 |
| Tarsons Products | 1,648 | 221.00 | 447 | 9.38% | 14 | 47.30 |
| Laxmi Dental | 1,101 | 33.80 | 286 | 18.15% | 26 | 58.13 |
| Hemant Surgical Industries | 887 | 51.40 | 238 | 112.99% | 18 | 51.83 |
| Q-Line Biotech | 1,047 | 18.40 | 347 | 7.89% | 56 | 32.49 |
| Vasa Denticity | 834 | 71.00 | 283 | 12.77% | 10 | 62.26 |
| Osel Devices | 615 | 22.50 | 295 | 57.88% | 29 | 43.28 |
| Fabtech Technologies | 615 | 17.00 | 431 | 28.40% | 38 | 54.95 |
Hemant Surgical Industries Company Announcements - News & Reports Screener
Screen HSIL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 17, 2026.
The next most recent announcements are dated November 17, 2026 and November 5, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-17 | Un-Audited Financial Results Of The Company For The Half Year Ended September 30 2026 | - |
| 2026-11-17 | Board Meeting Outcome for Meeting Held On November 14 2026 | - |
| 2026-11-05 | Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30 2026 | - |
| 2026-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-28 | Closure of Trading Window | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | The Company Has Issued Letters To Those ShareholderS Whose Email Addresses Are Not Registered With The Company/RTA/ Depository Participants. | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of The 37Th Annual General Meeting (AGM) Of The Company Will Be Held On Tuesday September 29 2026. | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-29 | Board Meeting Outcome for Held On August 29 2026 | - |
| 2026-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-09 | Revised Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USA | - |
| 2026-06-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 5.96. Market capitalisation stands at ₹887.34 Cr. The company operates in the Healthcare sector, in the Healthcare Equipment & Supplies industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 20, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.